Bullous/Mucous Membrane

In 2003, multiple studies were conducted on various skin conditions and their treatments. A retrospective review of 120 patients over a 10-year period found that antihypertensive agents were most commonly implicated in drug-induced cutaneous lupus erythematosus (CLE), with most patients seeing improvement within 8 weeks of discontinuing the offending drug. Other studies focused on conditions such as arsenicosis, diabetic foot ulcers, neonatal herpes simplex virus infection, pediatric vasculitis, localized scleroderma, and varicella. In terms of vaccines, a glycoprotein D-adjuvant vaccine was found to be 73% and 74% effective against genital herpes simplex virus in women who were seronegative for both HSV-1 and HSV-2. A vaccine against human papillomavirus type 16 reduced the incidence of HPV-16 infection and related cervical intraepithelial neoplasia. For psoriasis, NB-UVB phototherapy applied three times a week cleared the condition faster than twice-weekly applications. Other treatments for psoriasis and dermatitis were also explored, including Disperse Blue dyes, Disperse Orange 3, monoclonal antibodies, oral pimecrolimus, alefacept, and infliximab. Lastly, a study involving 194 females found no direct relationship between low serum ferritin and chronic diffuse telogen hair loss.